Title:
IMIDAZOPYRIDINE COMPOUND AS P53-MDM2 INHIBITOR
Document Type and Number:
WIPO Patent Application WO/2018/161871
Kind Code:
A1
Abstract:
Disclosed is a p53-MDM2 inhibitor compound having the structure of an imidazopyridine, and particularly disclosed are a compound as shown in formula (II) and a pharmaceutically acceptable salt thereof.
Inventors:
CHEN XINHAI (CN)
YAN XIAOBING (CN)
LIANG NA (CN)
HU GUOPING (CN)
LI JIAN (CN)
CHEN SHUHUI (CN)
DONG JIAQIANG (CN)
WANG TIE-LIN (CN)
YAN XIAOBING (CN)
LIANG NA (CN)
HU GUOPING (CN)
LI JIAN (CN)
CHEN SHUHUI (CN)
DONG JIAQIANG (CN)
WANG TIE-LIN (CN)
Application Number:
PCT/CN2018/078010
Publication Date:
September 13, 2018
Filing Date:
March 05, 2018
Export Citation:
Assignee:
LUOXIN BIOTECHNOLOGY SHANGHAI CO LTD (CN)
SHANDONG LUOXIN PHARMACY STOCK (CN)
MEDSHINE DISCOVERY INC (CN)
SHANDONG LUOXIN PHARMACY STOCK (CN)
MEDSHINE DISCOVERY INC (CN)
International Classes:
C07D471/04; A61K31/33; A61K31/4439; A61P35/00; C07D403/00; C07D487/04
Domestic Patent References:
| WO2015084804A1 | 2015-06-11 |
Foreign References:
| CN104203952A | 2014-12-10 | |||
| CN105209467A | 2015-12-30 | |||
| CN102603717A | 2012-07-25 |
Attorney, Agent or Firm:
SHANGHAI BESHINING LAW OFFICE (CN)
Download PDF: